1. Single- and multistep selection study of the antipneumococcal activity of BMS compared to ciprofloxacin, levofloxacin, trovafloxacin and moxifloxacin 
C.L. Clark, K. Nagai, T.A. Davies, B. Bozdogan, B. Dewasse, M.R. Jacobs, P.C. Appelbaum 
Clinical Microbiology and Infection 
Volume 8, Issue 6, Pages (June 2002)
DOI: /j x
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions

2. Figure 1
Time kill results, at two times the MIC, of four BMS resistant clones with MICs of 2 mg/L.
Clinical Microbiology and Infection 2002 8, DOI: ( /j x)
Copyright © 2002 European Society of Clinical Infectious Diseases Terms and Conditions